These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 799294)

  • 1. [Research in vitro on the anticryptococcal effects of various steroid hormones alone or in combination with antifungal agents].
    Piersantelli N; Robert L; Carlevaro C
    Pathologica; 1976; 68(985-986):547-60. PubMed ID: 799294
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased susceptibility of Cryptococcus neoformans to amphotericin B in the presence of steroids.
    Mohr JA; Tatem BA; Long H; Muchmore HG; Felton FG
    Sabouraudia; 1973 Jul; 11(2):140-2. PubMed ID: 4584201
    [No Abstract]   [Full Text] [Related]  

  • 3. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
    Srimuang S; Prariyachatigul C; Chaiprasert A; Rungsipanuratn W; Tanphaichitra D
    J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
    Poon M; Cronin DC; Wormser GP; Bottone EJ
    Arch Pathol Lab Med; 1988 Feb; 112(2):161-2. PubMed ID: 3276290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.
    Schwarz P; Janbon G; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2007 Jan; 51(1):383-5. PubMed ID: 17043122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Cryptococcus neoformans to steroids.
    Mohr JA; Long H; McKown BA; Muchmore HG
    Sabouraudia; 1972 Jul; 10(2):171-2. PubMed ID: 4557878
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD; Huston AC
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
    Chin CS; Cheong YM; Wong YH
    Med J Malaysia; 1989 Sep; 44(3):194-8. PubMed ID: 2696871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Further experimental data on clotrimazole: effectiveness against Cryptococcus neoformans, Sporothrix schenkii and Blastomyces dermatitidis Gilchrist].
    Barfuss T; Seeliger HP; Plempel M
    Mykosen; 1975 May; 18(5):221-32. PubMed ID: 1099444
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB; Sujatha S; Parija SC
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimycotic effect of chlorotritylimidazole on Candida and Cryptococcus neoformans].
    Ritzerfeld W; Weisbrod W
    Arzneimittelforschung; 1972 Dec; 22(12):2073-5. PubMed ID: 4575345
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.
    Fujita NK; Edwards JE
    Antimicrob Agents Chemother; 1981 Jan; 19(1):196-8. PubMed ID: 7018384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
    Abdel-Salam HA
    Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
    Barchiesi F; Giacometti A; Cirioni O; Arzeni D; Silvestri C; Kamysz W; Abbruzzetti A; Riva A; Kamysz E; Scalise G
    Peptides; 2007 Aug; 28(8):1509-13. PubMed ID: 17698253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolates of Cryptococcus neoformans serotype A or D from cerebrospinal fluid resistant to 5-fluorocytosine.
    Arsic V; Mitrovic S; Kranjcic-Zec I; Dzamic A
    J Chemother; 1995 Nov; 7 Suppl 4():90-2. PubMed ID: 8904119
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G; Kobayashi GS
    J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
    Borowski J; Jakoniuk P; JabloĊ„ska W; Jakubicz W; Szpak A
    Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.